406 related articles for article (PubMed ID: 28940895)
1. miR-339-5p downregulation contributes to Taxol resistance in small-cell lung cancer by targeting α1,2-fucosyltransferase 1.
Gan CZ; Li G; Luo QS; Li HM
IUBMB Life; 2017 Nov; 69(11):841-849. PubMed ID: 28940895
[TBL] [Abstract][Full Text] [Related]
2. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
[TBL] [Abstract][Full Text] [Related]
3. MiR-221-3p-mediated downregulation of MDM2 reverses the paclitaxel resistance of non-small cell lung cancer in vitro and in vivo.
Ni L; Xu J; Zhao F; Dai X; Tao J; Pan J; Shi A; Shen Z; Su C; Zhang Y
Eur J Pharmacol; 2021 May; 899():174054. PubMed ID: 33771522
[TBL] [Abstract][Full Text] [Related]
4. miR-30a-5p enhances paclitaxel sensitivity in non-small cell lung cancer through targeting BCL-2 expression.
Xu X; Jin S; Ma Y; Fan Z; Yan Z; Li W; Song Q; You W; Lyu Z; Song Y; Shi P; Liu Y; Han X; Li L; Li Y; Liu Y; Ye Q
J Mol Med (Berl); 2017 Aug; 95(8):861-871. PubMed ID: 28487996
[TBL] [Abstract][Full Text] [Related]
5. MiR-129-5p inhibits non-small cell lung cancer cell stemness and chemoresistance through targeting DLK1.
Ma Z; Cai H; Zhang Y; Chang L; Cui Y
Biochem Biophys Res Commun; 2017 Aug; 490(2):309-316. PubMed ID: 28619508
[TBL] [Abstract][Full Text] [Related]
6. miR-186 regulates chemo-sensitivity to paclitaxel via targeting MAPT in non-small cell lung cancer (NSCLC).
Ye J; Zhang Z; Sun L; Fang Y; Xu X; Zhou G
Mol Biosyst; 2016 Oct; 12(11):3417-3424. PubMed ID: 27714074
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7.
Pan X; Chen Y; Shen Y; Tantai J
Cell Death Dis; 2019 Jun; 10(6):429. PubMed ID: 31160576
[TBL] [Abstract][Full Text] [Related]
8. The miRNA-149-5p/MyD88 axis is responsible for ursolic acid-mediated attenuation of the stemness and chemoresistance of non-small cell lung cancer cells.
Chen Q; Luo J; Wu C; Lu H; Cai S; Bao C; Liu D; Kong J
Environ Toxicol; 2020 May; 35(5):561-569. PubMed ID: 31855318
[TBL] [Abstract][Full Text] [Related]
9. miR-17-5p downregulation contributes to paclitaxel resistance of lung cancer cells through altering beclin1 expression.
Chatterjee A; Chattopadhyay D; Chakrabarti G
PLoS One; 2014; 9(4):e95716. PubMed ID: 24755562
[TBL] [Abstract][Full Text] [Related]
10. miR-324-5p upregulation potentiates resistance to cisplatin by targeting FBXO11 signalling in non-small cell lung cancer cells.
Ba Z; Zhou Y; Yang Z; Xu J; Zhang X
J Biochem; 2019 Dec; 166(6):517-527. PubMed ID: 31778188
[TBL] [Abstract][Full Text] [Related]
11. MiR-142-5p Suppresses Tumorigenesis by Targeting PIK3CA in Non-Small Cell Lung Cancer.
Wang Z; Liu Z; Fang X; Yang H
Cell Physiol Biochem; 2017; 43(6):2505-2515. PubMed ID: 29131028
[TBL] [Abstract][Full Text] [Related]
12. miR-219a-5p enhances the radiosensitivity of non-small cell lung cancer cells through targeting CD164.
Wei T; Cheng S; Fu XN; Feng LJ
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32364222
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.
Mao M; Wu Z; Chen J
Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872
[TBL] [Abstract][Full Text] [Related]
14. Blocking hsa_circ_0074027 suppressed non-small cell lung cancer chemoresistance via the miR-379-5p/IGF1 axis.
Zheng S; Wang C; Yan H; Du Y
Bioengineered; 2021 Dec; 12(1):8347-8357. PubMed ID: 34592879
[TBL] [Abstract][Full Text] [Related]
15. MiR-634 sensitizes nasopharyngeal carcinoma cells to paclitaxel and inhibits cell growth both in vitro and in vivo.
Peng X; Cao P; He D; Han S; Zhou J; Tan G; Li W; Yu F; Yu J; Li Z; Cao K
Int J Clin Exp Pathol; 2014; 7(10):6784-91. PubMed ID: 25400759
[TBL] [Abstract][Full Text] [Related]
16. The relationship between miR-17-5p, miR-92a, and let-7b expression with non-small cell lung cancer targeted drug resistance.
Gong J; He L; Ma J; Zhang J; Wang L; Wang J
J BUON; 2017; 22(2):454-461. PubMed ID: 28534369
[TBL] [Abstract][Full Text] [Related]
17. miR-144-5p Enhances the Radiosensitivity of Non-Small-Cell Lung Cancer Cells via Targeting ATF2.
Song L; Peng L; Hua S; Li X; Ma L; Jie J; Chen D; Wang Y; Li D
Biomed Res Int; 2018; 2018():5109497. PubMed ID: 29850528
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-485-5p suppresses growth and metastasis in non-small cell lung cancer cells by targeting IGF2BP2.
Huang RS; Zheng YL; Li C; Ding C; Xu C; Zhao J
Life Sci; 2018 Apr; 199():104-111. PubMed ID: 29510198
[TBL] [Abstract][Full Text] [Related]
19. MiR-106b-5p Promotes Proliferation and Inhibits Apoptosis by Regulating BTG3 in Non-Small Cell Lung Cancer.
Wei K; Pan C; Yao G; Liu B; Ma T; Xia Y; Jiang W; Chen L; Chen Y
Cell Physiol Biochem; 2017; 44(4):1545-1558. PubMed ID: 29197876
[TBL] [Abstract][Full Text] [Related]
20. Involvement of miR-4262 in paclitaxel resistance through the regulation of PTEN in non-small cell lung cancer.
Sun H; Zhou X; Bao Y; Xiong G; Cui Y; Zhou H
Open Biol; 2019 Jul; 9(7):180227. PubMed ID: 31337279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
